peptidylprolyl isomerase A pseudogene 47Genealiases: []
Q-omics provides the consensus-scored PPIAP47 profile across patient tissues and cancer cell-line models. PPIAP47 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, PPIAP47 is differentially expressed in 10, with the highest sampling consensus in LUSC. Additionally, PPIAP47 RNA expression shows 8,912 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight ACC, LUSC, and TGCT as cancer lineages where PPIAP47 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PPIAP47 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes PPIAP47 survival associations across molecular data types. PPIAP47 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PPIAP47 RNA expression–survival associations across cancer types. High PPIAP47 expression shows unfavorable associations in ACC, UVM, LGG, LIHC and UCEC, but favorable associations in ESCA. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for PPIAP47 RNA expression.
This table summarizes PPIAP47 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for PPIAP47. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. PPIAP47 shows higher tumor expression in LUSC, BLCA, COAD, HNSC, LUAD and BRCA. The LUSC box plot shows higher PPIAP47 RNA expression in tumor versus normal tissue (log2 FC = +0.249, t-test p < 0.001).
This table shows molecular features associated with PPIAP47 in patient tissues and cancer cell lines. In patient samples, PPIAP47 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
